Recommended vaccinations for people with cardiovascular disease

Česká verzia

Authors: Dvořák J.
Authors place of work: Centra očkování a cestovní medicíny Avenier
Published in the journal: Kardiol Rev Int Med 2020, 22(1): 36-38

Summary

In Europe, 3.9 million people die of cardiovascular disease each year. The factors leading to the development of atherosclerotic plaques also include the inflammatory process and possibly also an infectious disease. Acute infectious diseases are associated with a high risk of complications, particularly acute myocardial infarction and other cardiac events, in persons with cardiovascular disease. Influenza and pneumococcal diseases are among the most serious infectious diseases associated with a high risk of acute myocardial infarction, arrhythmias or heart failure.

Keywords:

cardiovascular diseases – infectious diseases – influenza – pneumococcal diseases – vaccination

Zdroje

1. WHO. Cardiovascular diseases (CVDs) fact sheet. Available at: https:/ / www.who.int/ news-room/ fact-sheets/ detail/ cardiovascular-diseases-(cvds).

2. European heart network. European Cardiovascular Disease Statistics 2017. Available at: http:/ / www.ehnheart.org/ cvd-statistics.html.

3. Chlíbek R et al. Očkování dospělých. Praha: Mladá Fronta 2018: 200– 205.

4. Marti-Soler H, Gonseth S, Gubelmann C et al. Seasonal variation of overall and cardiovascular mortality: a study in 19 countries from different geographic locations. PLoS One 2014; 9(11): e113500. doi: 10.1371/ journal.pone.0113500.

5. MacIntyre CR, Mahimbo A, Moa AM et al. Influenza vaccine as a coronary intervention for prevention of myocardial infarction. Heart 2016; 102(24): 1953– 1956. doi: 10.1136/ heartjnl-2016-309983.

6. Veljkovic V, Glisic S, Veljkovic N et al. Colombatti. Influenza vaccine as prevention for cardiovascular diseases: Possible molecular mechanism. Vaccine 2014; 32(48): 6569– 6575. doi: 10.1016/ j.vaccine.2014.07.007.

7. Naghavi M, Barlas Z, Siadaty S et al. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2000; 102(25): 3039– 3045. doi: 10.1161/ 01.CIR.102.25.3039.

8. Lamontagne F, Garant FM, Carvalho JC et al. Pneumococcal vaccination and risk of myocardial infarction. CMAJ 2008; 179(8): 773– 777. doi: 10.1503/ cmaj.070221.